Table of Contents

company-logo

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The company has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.

ImmuPharma Dividend Announcement

• ImmuPharma announced a annually dividend of £1.00 per ordinary share which will be made payable on . Ex dividend date: 2021-12-14
• ImmuPharma's trailing twelve-month (TTM) dividend yield is -%

ImmuPharma Dividend History

Ex-Div dateDividend amountDividend typePay date
2021-12-14£1.00annually

ImmuPharma Dividend per year

ImmuPharma Dividend Yield

ImmuPharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing ImmuPharma stock? Use our calculator to estimate your expected dividend yield:

ImmuPharma Financial Ratios

P/E ratio-2.53
PEG ratio-116.98
P/B ratio2.32
ROE-131.41%
Payout ratio0.00%
Current ratio1.60
Quick ratio1.60
Cash Ratio0.79

ImmuPharma Dividend FAQ

Does ImmuPharma stock pay dividends?
ImmuPharma does not currently pay dividends to its shareholders.
Has ImmuPharma ever paid a dividend?
No, ImmuPharma has no a history of paying dividends to its shareholders. ImmuPharma is not known for its dividend payments.
Why doesn't ImmuPharma pay dividends?
There are several potential reasons why ImmuPharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will ImmuPharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While ImmuPharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is ImmuPharma a dividend aristocrat?
ImmuPharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is ImmuPharma a dividend king?
ImmuPharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is ImmuPharma a dividend stock?
No, ImmuPharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy ImmuPharma stocks?
To buy ImmuPharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy ImmuPharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.